|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: NOVAMETRIX MEDICAL SYSTEMS INC, 10-K, EX-23.1, 2000-07-27 |
Next: IEXALT INC, 8-K, 2000-07-27 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information extracted from the
audited Novametrix Medical Systems Inc. Consolidated Statements of Income
for the year ended April 30, 2000 and the Consolidated Balance Sheets at
April 30, 2000, and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> APR-30-2000
<PERIOD-START> MAY-1-1999
<PERIOD-END> APR-30-2000
<CASH> 283,262
<SECURITIES> 0
<RECEIVABLES> 17,580,814
<ALLOWANCES> (300,000)
<INVENTORY> 9,862,717
<CURRENT-ASSETS> 28,554,935
<PP&E> 11,378,687
<DEPRECIATION> 8,028,572
<TOTAL-ASSETS> 47,150,667
<CURRENT-LIABILITIES> 11,034,244
<BONDS> 5,850,601
0
0
<COMMON> 94,503
<OTHER-SE> 30,171,319
<TOTAL-LIABILITY-AND-EQUITY> 47,150,667
<SALES> 43,682,223
<TOTAL-REVENUES> 43,853,022
<CGS> 18,669,287
<TOTAL-COSTS> 18,669,287
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 999,803
<INCOME-PRETAX> 3,654,155
<INCOME-TAX> 1,189,330
<INCOME-CONTINUING> 2,464,825
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 223,544
<NET-INCOME> 2,241,281
<EPS-BASIC> $0.31
<EPS-DILUTED> $0.30
</TABLE>
|
|